Harmon Cyrus
Olema Pharmaceuticals, Inc. · Director
Harmon Cyrus is listed in filings as Director at Olema Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Jan 21, 2026, including sale activity. Recent filings connect the profile to Olema Pharmaceuticals, Inc. (OLMA). The current snapshot covers public activity from Jun 18, 2024 to Jan 21, 2026. Reported amounts are shown as $284.3K to $61.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $215k20k shares | SellJun 28, 2024 | $10.77 | $11.07 | |
| $61k5k shares | SellJul 11, 2024 | $12.26 | $11.07 | |
| $15k934 shares | SellJul 30, 2024 | $15.55 | $11.07 | |
| $63k4.1k shares | SellJul 29, 2024 | $15.58 | $11.07 | |
| $1.7k179 shares | SellDec 11, 2024 | $9.39 | $11.07 | |
| $69k8k shares | SellDec 11, 2024 | $8.66 | $11.07 | |
| $77k8.3k shares | SellDec 10, 2024 | $9.37 | $11.07 | |
| $26k3.1k shares | SellSep 18, 2025 | $8.32 | $11.07 | |
| $15k1.9k shares | SellSep 16, 2025 | $8.08 | $11.07 | |
| $83k10k shares | SellSep 18, 2025 | $8.33 | $11.07 | |
| $80k10k shares | SellSep 16, 2025 | $8.04 | $11.07 | |
| $82k2.9k shares | SellDec 22, 2025 | $28.53 | $11.07 | |
| $102k3.5k shares | SellJan 14, 2026 | $29.12 | $11.07 |